NewsBenzingaHC Wainwright & Co. ribadisce l'acquisto su Enanta Pharma, mantiene l'obiettivo di prezzo a $20 HC Wainwright & Co. ribadisce l'acquisto su Enanta Pharma, mantiene l'obiettivo di prezzo a $20 Benzinga 2026.09.23 10:45 (GMT+0) Open on Benzinga Other news Why Is Snowflake Stock Surging Monday? 18 Globo Titles Heading To Netflix In Unprecedented Licensing Agreement ImmunityBio Study Shows Long-Term Success for Bladder Cancer Treatment RBC Capital Maintains Outperform on Regions Financial, Lowers Price Target to $32 Wells Fargo Maintains Equal-Weight on Greif, Lowers Price Target to $88 Piper Sandler Maintains Overweight on GCM Grosvenor, Lowers Price Target to $14.5
